Your browser doesn't support javascript.
loading
Determining the Optimal Dosage of Dexmedetomidine for Smooth Emergence in Older Patients Undergoing Spinal Surgery: A Study of 44 Cases.
Ahn, Hyoeun; Chae, Yun Jeong; Choi, Gyu Bin; Lee, Min Gyu; Yoo, Ji Young.
Afiliação
  • Ahn H; Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine, Suwon, South Korea.
  • Chae YJ; Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine, Suwon, South Korea.
  • Choi GB; Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine, Suwon, South Korea.
  • Lee MG; Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine, Suwon, South Korea.
  • Yoo JY; Department of Anesthesiology and Pain Medicine, Ajou University School of Medicine, Suwon, South Korea.
Med Sci Monit ; 30: e944427, 2024 Jun 09.
Article em En | MEDLINE | ID: mdl-38851875
ABSTRACT
BACKGROUND Emergence agitation, or delirium, occurs during early recovery from general anesthesia and involves disorientation, excitation, and uncontrolled physical movements. Dexmedetomidine is an alpha agonist that has sedative, anxiolytic, analgesic, and sympatholytic activities and is used as a continuous infusion to prevent emergence agitation. This study aimed to evaluate patients aged 65 years and older undergoing general anesthesia to determine the 90% effective dose (ED90) of dexmedetomidine continuous intraoperative infusion to prevent emergence agitation. MATERIAL AND METHODS We enrolled 44 patients aged 65 years and older undergoing spinal surgery under general anesthesia. Dexmedetomidine administration commenced 30 minutes before surgery completion, with a predetermined infusion dose (µg/kg/h), without a loading dose. The initial dose was 0.2 µg/kg/h, and subsequent step size was ±0.05 µg/kg/h. We tried to find ED90 of dexmedetomidine using the biased-coin design. Vital signs, extubation quality scores, extubation-related complications, and postoperative outcomes were monitored. RESULTS Dexmedetomidine ED90 for smooth emergence in older patients was 0.34 µg/kg/h. Peri-extubation vital signs remained within 20% of baseline values, without requiring pharmacological intervention. No hypoxia, hypoventilation, or post-extubation agitation occurred. In the recovery room, 1 patient briefly exhibited excitement but quickly calmed. Nine patients initially unresponsive in the recovery room fully awoke and were promptly discharged. CONCLUSIONS For older patients who are vulnerable to adverse effects of anesthetics and opioids, dexmedetomidine enables gentle awakening without adverse vital sign changes, respiratory depression, excessive sedation, or emergence agitation (ED90=0.34 µg/kg/h). Further studies should involve a larger patient cohort, considering diverse medical conditions in older individuals.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Período de Recuperação da Anestesia / Dexmedetomidina / Hipnóticos e Sedativos Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Med Sci Monit Assunto da revista: MEDICINA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Coréia do Sul

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Período de Recuperação da Anestesia / Dexmedetomidina / Hipnóticos e Sedativos Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Revista: Med Sci Monit Assunto da revista: MEDICINA Ano de publicação: 2024 Tipo de documento: Article País de afiliação: Coréia do Sul